COM:FOGHORNTX
Foghorn Therapeutics Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Biopharmaceuticalwebsite
foghorntx.comcrunchbase
foghorn-therapeuticslinkedin
foghorn-therapeuticsfounding date
Jan 01, 2015ipo date
Oct 23, 2020
Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-286, a small molecule inhibitor of ...Show More